Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedA recruitment status update 'No longer looking for participants' was added, indicating that enrollment for the EMBRACA study is closed. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a revision tag update to v3.6.0 were introduced, while the Interventions/Treatment heading formatting was adjusted.SummaryDifference0.1%

- Check19 days agoChange DetectedThe revision history now shows v3.5.5, replacing the previous v3.5.4 and indicating a minor update to the page's version history.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays a new revision label (v3.5.4) replacing the previous v3.5.3, indicating a backend/template update rather than changes to the study information.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now displays Revision: v3.5.3 in the footer, replacing the previous Revision: v3.5.2. This indicates a software update to the page rather than a change to study details or content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision label was updated from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check91 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.